FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Circulating Tumor Cells Market is poised to register a CAGR of 11.7% during the forecast period 2022 to 2028:

FutureWise Market Research has instantiated a report that provides an intricate analysis of Circulating Tumor Cells Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Circulating Tumor Cells Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register anoteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Circulating Tumor Cells Market are :

• QIAGEN
• Bio-Techne Corporation
• Precision for Medicine
• AVIVA Biosciences
• BIOCEPT, Inc.
• BioCEP Ltd.
• Fluxion Biosciences, Inc.
• Greiner Bio One International GmbH.
• Ikonisys Inc.
• Miltenyi Biotec
• IVDiagnostics
• BioFluidica
• Creativ MicroTech, Inc.
• LungLife AI, Inc.
• Epic Sciences
• Rarecells Diagnostics
• ScreenCell
• Menarini Silicon Biosystems
• LineaRx, Inc. (Vitatex, Inc.)
• Sysmex Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

Circulating Tumor Cells Market Segmentation:

By Technology
• CTC Detection
Enrichment Methods
o Immunocapture (Label-based)
• Positive Selection
• Negative Selection
o Size-based Separation (Label-free)
• Membrane-based
• Microfluidic-based
o Density-based Separation (Label-free)
o Combined Methods
• CTC Direct Detection Methods
o SERS
o Microscopy
o Others
• CTC Analysis
By Application
• Clinical/ Liquid Biopsy
o Risk Assessment
o Screening and Monitoring
• Research
o Cancer Stem Cell
Tumorigenesis Research
o Drug/Therapy Development
By Product
• Kits
Reagents
• Blood Collection Tubes
• Devices or Systems
By Specimen
•
Blood
•
Bone Marrow
•
Other Body Fluids
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Circulating Tumor Cells Market by technology, by application, by product, by specimen and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.

• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Circulating Tumor Cells Market Variables, Trends
- Scope
  1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Circulating Tumor Cells Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Circulating Tumor Cells Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Circulating Tumor Cells Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
- 1. CTC Detection
  Enrichment Methods
  1.1. Immunocapture (Label-based)
  1.1.1. Positive Selection
  1.1.2. Negative Selection
  1.2. Size-based Separation (Label-free)
  1.2.1. Membrane-based
  1.2.2. Microfluidic-based
  1.3. Density-based Separation (Label-free)
  1.4. Combined Methods
  2. CTC Direct Detection Methods
  2.1. SERS
  2.2. Microscopy
  2.3. Others
  3. CTC Analysis
8. Circulating Tumor Cells Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
- 1. Clinical/ Liquid Biopsy
  1.1. Risk Assessment
  1.2. Screening and Monitoring
  2.Research
  2.1. Cancer Stem Cell
  Tumorigenesis Research
  2.2. Drug/Therapy Development
9. Circulating Tumor Cells Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
- 1. Kits
  Reagents
  2. Blood Collection Tubes
  2. Devices or Systems
10. Circulating Tumor Cells Market, By Specimen Historical Analysis and Forecast 2022-2028 (USD Million)
- 1. Blood
  2. Bone Marrow
  3. Other Body Fluids
11. North America Circulating Tumor Cells Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Circulating Tumor Cells Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Circulating Tumor Cells Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Circulating Tumor Cells Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. QIAGEN
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Bio-Techne Corporation
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Precision for Medicine
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. AVIVA Biosciences
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. BIOCEPT, Inc.
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. BioCEP Ltd.
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Fluxion Biosciences, Inc.
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Greiner Bio One International GmbH.
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Ikonisys Inc.
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10.Miltenyi Biotec
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11.IVDiagnostics
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12.BioFluidica
  12.1. Company Overview
  12.2. Product Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13.Creativ MicroTech, Inc.
  13.1. Company Overview
  13.2. Product Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
  14.LungLife AI, Inc.
  14.1. Company Overview
  14.2. Product Portfolio
  14.3. SWOT Analysis
  14.4. Financial Overview
  14.5. Strategic Overview
  15.Epic Sciences
  15.1. Company Overview
  15.2. Product Portfolio
  15.3. SWOT Analysis
  15.4. Financial Overview
  15.5. Strategic Overview
  17.Rarecells Diagnostics
  1. Company Overview
  2. Product Portfolio
  3. SWOT Analysis
  4. Financial Overview
  5. Strategic Overview
  17.ScreenCell
  1. Company Overview
  2. Product Portfolio
  3. SWOT Analysis
  4. Financial Overview
  5. Strategic Overview
  18.Menarini Silicon Biosystems
  18.1. Company Overview
  18.2. Product Portfolio
  18.3. SWOT Analysis
  18.4. Financial Overview
  18.5. Strategic Overview
  19.LineaRx, Inc. (Vitatex, Inc.)
  19.1. Company Overview
  19.2. Product Portfolio
  19.3. SWOT Analysis
  19.4. Financial Overview
  19.5. Strategic Overview
  20.Sysmex Corporation
  20.1. Company Overview
  20.2. Product Portfolio
  20.3. SWOT Analysis
  20.4. Financial Overview
  20.5. Strategic Overview
18. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1850

Single user license: Single user license: $4250

Multi user license: Multi user license: $5450

Corporate license: Corporate license: $7800

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients